Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Published Phase 2 data (NEJM, 2023) showed retatrutide achieving up to 24.2% mean weight reduction at 48 weeks exceeding outcomes seen with dual GLP-1/GIP agonists
Cholesterol induces Nrf-2- and HIF-1-dependent hepatocyte proliferation and liver regeneration to ameliorate bile acid toxicity in mouse models of NASH and fibrosis
[1] While this effect is generally mild, patients with pre-existing cardiovascular conditions should be monitored
Aetna will not cover Ozempic, Wegovy, or any branded semaglutide for prediabetes
Expected Results Gradual improvement in skin brightness and reduction in dark spots within 48 weeks
Retatrutide works through three receptor systems simultaneously
US$ 21.46
US$ 23.70
US$ 24.12
US$ 24.10
